Prevalence of Drug Allergy Labels Among Pediatric Patients With Inborn Errors of Immunity
Annals of Allergy, Asthma and Immunology · Published 2026-08-01 · DOI 10.1016/j.anai.2026.07.029
Authors (5)
Jack R. Mudge, Brenna LaBere, Michell Lozano Chinga, Holly K. Miller, Christine R.F. Rukasin
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Mudge, J., LaBere, B., Chinga, M., et al. (2026). Prevalence of Drug Allergy Labels Among Pediatric Patients With Inborn Errors of Immunity. Annals of Allergy, Asthma and Immunology. https://doi.org/10.1016/j.anai.2026.07.029
Related articles
- Authors’ response · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Remission and meaningful outcomes in chronic rhinitis and rhinosinusitis · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Fish-induced food protein-induced enterocolitis syndrome (FPIES) in children: Geography matters and tolerance is more than a challenge date · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Small airway dysfunction and prior exacerbations are common in primarily well-controlled pediatric asthma · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Overlapping mechanisms and novel biomarkers define asthma and chronic obstructive pulmonary disease (COPD) as a spectrum of airway diseases · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Predictive value of the hemoglobin, albumin, lymphocyte, and platelet score for mortality in asthma · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Authors' response · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Precision medicine in atopic dermatitis · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Refining pediatric eczema severity assessment with Three-Item Severity score and Patient-Oriented Eczema Measure · Annals of Allergy, Asthma and Immunology · 2026 · Same journal
- Thrombotic event risk among omalizumab users vs nonusers · Annals of Allergy, Asthma and Immunology · 2026 · Same journal